GlassScriptPhysician profile
Hemangini Patel
NPI 1558761924
$4,188.14
in general payments reported to CMS, 2019-2025
19 companies · $1,344 in 2025
The $1,344 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $376 · 2023: $429 · 2024: $1,606 · 2025: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,378.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $590.98 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $497.15 | 2021-2024 | |
| Incyte Corporation | $425.61 | 2022-2025 | Opzelura |
| Ucb, INC. | $424.49 | 2024-2025 | Bimzelx |
| Abbvie INC. | $411.23 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $367.85 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $197.42 | 2022-2025 | |
| Dermavant Sciences, INC. | $190.23 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $177.68 | 2023-2025 | Zoryve |
| Pfizer INC. | $171.82 | 2021-2025 | |
| Janssen Biotech, INC. | $164.93 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Sun Pharmaceutical Industries INC. | $148.62 | 2022-2023 | Winlevi, Absorica Ld |
| Leo Pharma INC. | $106.42 | 2021-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $86.17 | 2022-2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $63.58 | 2021-2024 | Jublia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $53.94 | 2024 | Klisyri |
| Vyne Pharmaceuticals INC. | $53.00 | 2021 | |
| Galderma Laboratories, L.P. | $45.00 | 2025 | Nemluvio |
| Epi Health, LLC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemangini Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.